At the beginning of the year, the pandemic presented great challenges for existing clinical trials and continues to impact new trials as well.  So since then, what have we learned and how can we overcome these challenges?

This insightful video will show you how the industry’s leading IRT provider was able to pivot and adapt to keep trials up and running while implementing key adaptations in a purposeful way to new studies.

Learn how they are accomplishing shorter timelines and ensuring that future decentralized trials succeed.

You will learn:

• Our challenging landscape – existing pipelines vs COVID-19 pipelines
• IRT setting changes that can make a positive impact for supply chain and distribution strategies
• New distribution approaches that can benefit your trial